Strides Pharma Science Limited — Important, 19-03-2025: General Updates

Strides Pharma Science has announced a board meeting regarding the proposed demerger of the identified business of its wholly-owned subsidiary, Arco Lab. This strategic move aims to transfer Arco Lab's Life Sciences and Digital Innovation capabilities into a newly formed entity, NewCo, which will focus on life sciences and manufacturing solutions. The initiative is expected to streamline operations without any financial impact on Strides. Investors may view this development positively, as it could enhance focus on core capabilities and create new growth opportunities through specialized solutions.